A new UC San Diego analysis of 21,189 adults aged 65+ found 11.4% of past-year cannabis users met DSM-5 criteria for cannabis use disorder, with most cases mild.

A federally funded survey of older adults reports surprising day-of use, common medical motivations, and preferred THC delivery methods—data clinicians and DMV families should note.

Marijuana Moment reports a Texas Senate candidate’s alcohol-linked cash haul while opposing cannabis reform—plus new research on teen use and clinical science DMVers should track.

Marijuana Venture spotlights Chris Violas in its 40 Under 40. We examine how tech‑minded leadership can shape patient delivery services, science‑based safeguards, and DMV implications.

A new Nebraska Senate ad spotlights Pete Ricketts’s past line that legalization would “kill your kids,” while federal stances on rescheduling, 280E and banking keep delivery rules in flux.

Gov. Maura Healey files a budget provision allowing veterans with qualifying VA diagnoses to join state medical programs without secondary physician sign-offs.

A new GAO report says DEA and FDA lack clear drug-scheduling procedures just as an ALJ reviews moving cannabis to Schedule III and court fights continue.

Definium Therapeutics reports another positive Phase 3 readout for DT120 in generalised anxiety disorder, with randomized data from the Panorama study now toplined.

A DC patient helped coin “medical marijuana” 50 years ago. Here’s why the language still shapes delivery laws, licensing, and transport compliance across the DMV.

A little-known 1969 cannabis journal argued the core points the DEA just made on rescheduling—raising new stakes for patients, researchers, and the DMV in 2026.

A clear, evidence-aware guide to the Super Boof cannabis strain, including its reported genetics, flavor, effects, potency, cultivation profile, and what DMV consumers should know.

A clear, evidence-minded guide to the Cap Junky weed strain, including its hybrid identity, commonly reported potency, terpene profile, effects, cultivation basics, and what DMV consumers should know.

After public feedback, Oregon’s health regulators shelved a proposal to double psilocybin licensing fees and will restart rulemaking, with other changes eyed for 2027.

Maine’s cannabis regulator is distributing 12,000 free lockable storage bags through 140 retailers and caregivers, more than doubling last year’s pilot and prioritizing youth and pet safety.

A new federal appeals ruling threatens enforcement of cannabis deals in U.S. courts. Here’s how delivery operators, investors, and DMV entrepreneurs can protect revenue and reduce risk.

Alabama health officials unanimously withdrew their objection to potential federal rescheduling of medical cannabis, while the state program continues despite cannabis remaining Schedule I under Alabama law.

A clear, evidence-aware guide to the Super Boof cannabis strain, including its reported genetics, flavor, effects, potency, cultivation profile, and what DMV consumers should know.

Linalool’s calming aroma shows promise for anxiety, sleep, pain, and skin care. Here’s the science, safety tips, and how DMV patients can use terpene data wisely.

A small Johns Hopkins pilot gave two psilocybin doses to 20 adults with chronic Lyme symptoms. Participants reported improved sleep and quality of life, and a 40% symptom drop at six months.

A federal health R&D push is exploring ibogaine for opioid use disorder. Here’s what the ARPA-H workshop and ASCENT-IBO call mean for patients and the DMV.